Riskpilot← Back to searchSign inGet full accessiDocMed Oy
OYActiveY-tunnus 2197719-5Puolaharju 35-AMedical specialists activities · NACE 8622Est. 20082 employees
Revenue 2024
EUR 769K
-18% vs 2023
EBITDA margin
46.3%
-47% vs 2023
Equity ratio
91.2%
Financial strength
Net profit 2024
EUR 595K
-22% vs 2023
| Revenue | EUR 769K | -18% |
| EBITDA | EUR 356K | -47% |
| Net profit | EUR 595K | -22% |
| Total assets | EUR 4,3M | +6% |
| Equity | EUR 3,9M | +13% |
| Employees | 2 | — |
Legal name
iDocMed Oy
Y-tunnus number
2197719-5
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
23. toukokuuta 2008
Share capital
EUR 2 500
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on terveydenhoitopalveluiden, lääkäripalveluiden sekä laboratoriopalveluiden tuottaminen potilaille ja kaikki muu laillinen liiketoiminta.
Address
Puolaharju 35-A
Phone
+3580503231333
Email
ilpo.tuisku@helsinki.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 778 | 989 | 1 034 | 937 | 769 |
| Staff expenses | −90 | −92 | −88 | −108 | −199 |
| EBITDA | 550 | 742 | 752 | 667 | 356 |
| Depreciation & amort. | −3 | −45 | −15 | −59 | −75 |
| EBIT | 547 | 697 | 737 | 608 | 281 |
| Net financials | 6 | 152 | −89 | 287 | 376 |
| Profit before tax | 553 | 849 | 647 | 895 | 657 |
| Tax | 106 | 159 | 139 | 130 | 62 |
| Net profit | 447 | 690 | 508 | 765 | 595 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 384 | 3 358 | 3 572 | 4 011 | 4 259 |
| Equity | 1 990 | 2 530 | 2 832 | 3 447 | 3 885 |
| Long-term debt | 280 | 643 | 390 | 432 | 270 |
| Short-term debt | 114 | 185 | 350 | 131 | 104 |
| Total debt | 394 | 828 | 740 | 564 | 374 |
EBITDA margin
46.3%
This company
15.8%
Market median
+193% vs market
20202024
Equity ratio
91.2%
This company
38.2%
Market median
+139% vs market
20202024
Return on equity
15.3%
This company
18.4%
Market median
+17% vs market
20202024
Net profit margin
77.3%
This company
8.1%
Market median
+854% vs market
20202024
Asset turnover
0.18×
This company
1.12×
Market median
-84% vs market
20202024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
IS Chief Executive Officer | Chief Executive Officer | 2008 |
TT | Audit | 2015 |
TM Deputy Member | Deputy Member | 2008 |
VJ Deputy auditor | Deputy auditor | 2025 |
| Former (1) | ||
MA Deputy auditor | Deputy auditor | 2015 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Chairperson | 2008 | |
| Board of Directors | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of iDocMed Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ilpo Seppo Johannes Tuisku | Chief Executive Officer | 0 companies |
| Tarja Tuulikki Tolvanen | Audit | 0 companies |
| Marjatta Anneli Paananen | Deputy auditor | 0 companies |
| Tapani Martti Seppo Tuisku | Deputy Member | 0 companies |
| Virve Janniina Haavisto | Deputy auditor | 0 companies |
| Matias Martin Johannes Tuisku | Board of Directors | 0 companies |
| Johanna Ellimaria Tuisku | Chairperson | 0 companies |
| Tom Oskar Johannes Tuisku | Board of Directors | 0 companies |